Category: Covid News

CDC Has Not Been Transparent With the American Public on COVID

An article recently published in The New York Times highlights a glaring problem with the U.S. Centers for Disease Control and Prevention (CDC) and its policy recommendations related to the pandemic during the past two years. The problem has to do with lack of transparency regarding hospitalizations for COVID-19 and the effectiveness of vaccinations for the illness. The Times article,…


FDA Shifts Authorizations for Two COVID-19 Therapies Because of Omicron Subvariants

U.S. drug regulators have shifted language on two monoclonal antibody medicines because of emerging subvariants of the Omicron virus variant. The Food and Drug Administration (FDA) in recent days stipulated that an antibody treatment from GlaxoSmithKline and Vir Biotechnology cannot be used in regions where COVID-19 cases are likely to be caused by a variant…


CDC Drastically Alters Key Measure That Influences Mask Mandates Across US

The Centers for Disease Control and Prevention (CDC) on Feb. 25 drastically changed a key measure that is used by officials across the country to determine whether or not to require mask-wearing. The federal agency now says nearly three-quarters of Americans don’t need to wear masks because they live in areas with low or medium…


Can Algae-Based Nasal Spray Prevent COVID-19?

A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19, according to a new study. Researchers are making a molecule called Q-griffithsin using an anti-viral protein found in the New Zealand red algae Griffithsia and Nicotiana benthamiana, a plant in the same family as tobacco plants. The former…


CDC Under Fire for Not Publishing All COVID-19 Data It Collects

A top U.S. agency is under fire for withholding some of the COVID-19 data it collects. The Centers for Disease Control and Prevention (CDC) confirmed to The Epoch Times that it has not published some of the data it collected on COVID-19 reinfections. The spokesperson said it dropped plans for publishing a paper based on…


Vaccinated People More Likely to Contract COVID-19, Go to Hospital in Recent Weeks: CDC Data

COVID-19 case and hospitalization rates increased among people who got a COVID-19 vaccine following the emergence of the Omicron virus variant, according to newly published data from the Centers for Disease Control and Prevention (CDC). According to the data, which is submitted to the CDC by health departments across the country, the COVID-19 case rate…


COVID-19 Cases, Hospitalizations Jump Among Vaccinated: CDC Data

COVID-19 case and hospitalization rates increased among people who got a COVID-19 vaccine following the emergence of the Omicron virus variant, according to newly published data from the Centers for Disease Control and Prevention (CDC). According to the data, which is submitted to the CDC by health departments across the country, the COVID-19 case rate…


Reinfections With Subvariant of Omicron Are Rare, Danish Researchers Find

People who contract cases of COVID-19 caused by the Omicron virus variant are unlikely to get re-infected by a subvariant of the variant, researchers in Denmark found. Emerging data indicate BA.2, a subvariant of Omicron, is more transmissible—possibly 30 percent more, according to the World Health Organization. But an analysis of data from national surveillance…


A Betrayal of the Precautionary Principle

Making difficult decisions in the face of uncertainty is a common feature of all crises. The pandemic was no exception but, sadly, much of the decision-making was conducted under a misapprehension (and, occasionally, wilful distortion) of the uncertainties involved. The biggest uncertainty was the extent to which non-pharmaceutical interventions would curb the spread of infection….


Sanofi and GSK Say COVID-19 Vaccine Did Well in Trial, Will Seek US Clearance

A COVID-19 vaccine created by Sanofi and GlaxoSmithKline (GSK) performed well in a clinical trial, the companies said on Feb. 23. The vaccine was 100 percent effective against hospitalization, 75 percent effective against moderate to severe disease, and 58 percent effective against any symptoms, the companies said in a joint statement. The phase 3 trial,…